Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 45 for “"ADAMTS13"”.

  1. Mechanism of ADAMTS13 regulation

    Studies demonstrated ADAMTS13 possesses unique properties with a mystifying regulatory mechanism. ADAMTS13’s role is in its proteolytic function to its VWF. The disparity in the hemostatic balance between ADAMTS13 activity and the distribution of VWF multimers could result in the bleeding disorder …

    mcmaster Repository record for Mechanism of ADAMTS13 regulation (opens in a new tab)

  2. Characterizing Protease-Resistant ADAMTS13 Mutants

    ADAMTS13 is a metalloprotease that regulates the length, and thus, the platelet-capturing capacity of von Willebrand factor. The regulation of ADAMTS13 activity remains poorly understood. Numerous circulating proteases cleave ADAMTS13 in vitro, impairing its activity, but the physiological …

    mcmaster Repository record for Characterizing Protease-Resistant ADAMTS13 Mutants (opens in a new tab)

  3. ADAMTS13 Activity in Dogs with Chronic Enteropathies

    … with a thrombospondin type 1 motif, member 13 (ADAMTS13), a von Willebrand factor (vWF) cleaving enzyme, and increased circulating vWF. The primary aim of this study is to assess plasma ADAMTS13 activity, vWF antigen (vWF:Ag) concentration, and vWF collagen binding activity (vWF:CBA) in dogs …

    vt Repository record for ADAMTS13 Activity in Dogs with Chronic Enteropathies (opens in a new tab)

  4. ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

    … TTP is associated with the severe deficiency of ADAMTS13 (activity <10%), the metalloprotease responsible for the proteolytic regulation of VWF multimers size. In the acquired form of the disease, the severe deficiency of ADAMTS13 is caused by anti-ADAMTS13 antibodies that inhibit ADAMTS13 …

    milano Repository record for ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (opens in a new tab)

  5. Development of an ADAMTS13-based Therapy for Thrombosis

    Recombinant ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13)-based therapies were approved by the FDA to treat congenital thrombotic thrombocytopenic purpura (TTP), and preclinical studies have demonstrated its efficacy in mice. However, ADAMTS13 is …

    mcmaster Repository record for Development of an ADAMTS13-based Therapy for Thrombosis (opens in a new tab)

  6. Studies of ADAMTS13 expression and activity in the kidney

    … and aggregation at sites of vascular injury. ADAMTS13 is the sole physiological VWF-cleaving protease, thus regulating the size of thrombus growth. Dysfunctional ADAMTS13 leads to thrombotic thrombocytopenic purpura (TTP), which is either due to mutations (congenital TTP) or auto-antibodies …

    lund Repository record for Studies of ADAMTS13 expression and activity in the kidney (opens in a new tab) Download PDF for Studies of ADAMTS13 expression and activity in the kidney (opens in a new tab)

  7. Unraveling the mechanism of ADAMTS13 resistance to protease inhibition

    Background: ADAMTS13 is a metalloprotease that regulates the delicate balance between VWF multimeric length and its platelet capturing capacity. Unlike other ADAMTS and coagulation proteases, ADAMTS13 exhibits a prolonged half-life of several days as an active protease, suggesting that it is …

    mcmaster Repository record for Unraveling the mechanism of ADAMTS13 resistance to protease inhibition (opens in a new tab)

  8. Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease

    … cascade. vWF is cleaved by the metalloprotease ADAMTS13, regulating the multimers size, which hinders vWF’s ability to function properly. The three main types of vWD —Type I, II, and III— are not well defined, and as a result are all similarly treated with plasma-derived vWF replacement therapy. …

    dominican Repository record for Determination of ADAMTS13 Susceptibility in Type IIA von Willebrand Disease (opens in a new tab)

  9. Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions

    ADAMTS13 (A Disintegrin And Metalloprotease with ThromboSpondin type1 repeats-13) is an enzyme that is mainly synthesized in the liver and secreted into the blood stream. In plasma, ADAMTS13 cleaves ultra large (UL) von Willebrand factor (VWF) newly released from stimulated and/or injured …

    penn Repository record for Regulation of Adamts13 Function in Hemostasis by Cofactor and Substrate Exosite interactions (opens in a new tab)

  10. Plasma ADAMTS13 activity in dogs with severe thrombocytopenia and presumed immune thrombocytopenia

    Background: In humans, deficiency of plasma ADAMTS-13, a von Willebrand factor cleaving enzyme, is an important cause of thrombocytopenia in immune thrombotic thrombocytopenic purpura (iTTP). This disease can be difficult to differentiate from immune thrombocytopenia (ITP) in people. Further …

    vt Repository record for Plasma ADAMTS13 activity in dogs with severe thrombocytopenia and presumed immune thrombocytopenia (opens in a new tab)

  11. Ο ρόλος του άξονα vWF-ADAMTS13 στην παθοφυσιολογία της Δρεπανοκυτταρικής Νόσου. Τρέχουσες και μελλοντικές προοπτικές

    … μοντέλα στρέφονται στην διόρθωση του άξονα ADAMTS13-vWF με στόχο την μειωμένη παραγωγή των μεγάλων πολυμερών σε μια προσπάθεια περιορισμού της εξέλιξης των επώδυνων κρίσεων. Τα αποτελέσματα ενισχύουν την άποψη ότι ο ενδοθηλιακός vWF συμβάλλει στην παθογένεση του αγγειοαποφρακτικού επεισοδίου …

    athens Repository record for Ο ρόλος του άξονα vWF-ADAMTS13 στην παθοφυσιολογία της Δρεπανοκυτταρικής Νόσου. Τρέχουσες και μελλοντικές προοπτικές (opens in a new tab)

  12. Μελέτη των πολυμορφισμών του γονιδίου που κωδικοποιεί την πρωτεΐνη Adamts 13 σε έγκυες γυναίκες και συσχέτισή τους με την εμφάνιση προεκλαμψίας

    … This study aimed to examine the involvement of ADAMTS13, von Willebrand, and the complement system in the pathogenesis of preeclampsia/HELLP syndrome. We studied 30 Caucasian preeclamptic pregnant women and a control group of 15 healthy pregnancies. Genetic sequencing of ADAMTS13 and complement …

    greece Repository record for Μελέτη των πολυμορφισμών του γονιδίου που κωδικοποιεί την πρωτεΐνη Adamts 13 σε έγκυες γυναίκες και συσχέτισή τους με την εμφάνιση προεκλαμψίας (opens in a new tab)

  13. The effect of single nucleotide polymorphisms and mutations on congenital thrombotic thrombocytopenic purpura phenotype

    … of the von Willebrand factor cleaving protease (ADAMTS13). Over 100 mutations have been identified in ADAMTS13 yet, in some cases, these mutations in congenital TTP alone do not explain the disease phenotype, particularly in late-onset congenital TTP. One aim of this study was to analyse the …

    westminster Repository record for The effect of single nucleotide polymorphisms and mutations on congenital thrombotic thrombocytopenic purpura phenotype (opens in a new tab) Download PDF for The effect of single nucleotide polymorphisms and mutations on congenital thrombotic thrombocytopenic purpura phenotype (opens in a new tab)

  14. Διαταραχές αιμόστασης σε ασθενείς με καρδιακές αρρυθμίες, μελέτη του ενδοθηλίου, παράγοντας vWF, ADAMTS13, θρομβομοντουλίνης (TM), ιστικού παράγοντα (TF)

    … όπως της δυσλειτουργίας του ενδοθηλίου, της ADAMTS13, του παράγοντα Von Willebrand, της θρομβομοντουλίνης και του ιστικού παράγοντα. Αυτή η εργασία ανασκόπησης συνοψίζει την τρέχουσα βιβλιογραφία σχετικά με τον ρόλο του ενδοθηλίου και αυτών των βιοδεικτών στις διαταραχές αιμόστασης σε …

    athens Repository record for Διαταραχές αιμόστασης σε ασθενείς με καρδιακές αρρυθμίες, μελέτη του ενδοθηλίου, παράγοντας vWF, ADAMTS13, θρομβομοντουλίνης (TM), ιστικού παράγοντα (TF) (opens in a new tab)

  15. The association of von Willebrand factor and its cleaving protease (ADAMTS13) with health behaviours in young black and white adults: the African-PREDICT study

    … VIII from proteolysis. vWF is regulated by ADAMTS13 (A Disintegrin And Metalloproteinase with a ThromboSpondin type 1 motif, member 13) that cleaves vWF into smaller, less reactive molecules. Previous reports suggest that modifiable lifestyle factors such as physical activity, diet and …

    nwu-za Repository record for The association of von Willebrand factor and its cleaving protease (ADAMTS13) with health behaviours in young black and white adults: the African-PREDICT study (opens in a new tab)

  16. Interaction Between the Metalloprotease ADAMTS-13 and the Proteins of the Alternative Pathway of the Complement System

    … who can not cleave VWF multimers due to genetic ADAMTS13 deficiency, we investigated the mechanism through which VWF modulates complement, and its pathophysiological implications for human diseases. Using assays of ex-vivo serum-induced C3 and C5b-9 deposits on endothelial cells we documented …

    the-open-u Download PDF for Interaction Between the Metalloprotease ADAMTS-13 and the Proteins of the Alternative Pathway of the Complement System (opens in a new tab)

  17. The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance

    … size of VWF. The VWF-specific metalloprotease ADAMTS13 decreases VWF multimer size by cleaving at Y1605-M1606 in the VWF A2 domain. This thesis examined the sensitivity of ADAMTS13 cleavage to mutagenesis of the full-length multimerized VWF substrate, and a small VWF A2 domain fragment, VWF115. …

    queens Repository record for The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance (opens in a new tab)

  18. PATHOPHYSIOLOGY OF VON WILLEBRAND FACTOR IN BLEEDING AND THROMBOSIS

    … aimed to evaluate whether the reduction of ADAMTS13 activity or the alteration of ADAMTS13-VWF equilibrium may play a role in DVT pathogenesis. In Chapter 7, we performed a case-control study to evaluate the association between ADAMTS13, VWF, and FVIII plasma levels and DVT. We showed that a …

    milano Repository record for PATHOPHYSIOLOGY OF VON WILLEBRAND FACTOR IN BLEEDING AND THROMBOSIS (opens in a new tab)

Page 1 of 3